Metropolitan Digital

The Times


.

The FDA's lax oversight of research in developing countries can do harm to vulnerable participants

  • Written by C. Michael White, Distinguished Professor and Head of the Department of Pharmacy Practice, University of Connecticut
The FDA's lax oversight of research in developing countries can do harm to vulnerable participantsNearly 80% of participants in FDA-reviewed research trials live in foreign countries.Bet_Noire/iStock via Getty Images

The Research Brief is a short take about interesting academic work.

The Big Idea

The Food and Drug Administration provides less stringent oversight of overseas research trials used in deciding whether to approve a drug than those...

Read more: The FDA's lax oversight of research in developing countries can do harm to vulnerable participants

hacklink hack forum hacklink film izle hacklink z-libraryRomabetnon GAMSTOP casinosgrandpashabetgrandpashabetgrandpashabetDeneme bonusu veren siteler 2026Deneme bonusu veren siteler 2026Romabetjojobet giriş爱思助手下载jojobetjojobetjojobetmarsbahisjojobetjojobetjojobetjojobetjojobettelegram下载jojobet girişgrandpashabetcasino sitelerijojobet有道翻译下载betasus girişcasibomjojobetkingroyaljojobetgrandpashabetjojobetgrandpashabetjojobet